scispace - formally typeset
J

John T. Thompson

Researcher at Greater Baltimore Medical Center

Publications -  81
Citations -  3389

John T. Thompson is an academic researcher from Greater Baltimore Medical Center. The author has contributed to research in topics: Vitrectomy & Visual acuity. The author has an hindex of 34, co-authored 81 publications receiving 3179 citations. Previous affiliations of John T. Thompson include Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Vitrectomy for idiopathic epiretinal membranes causing macular pucker.

TL;DR: Vision improved postoperatively in 61 eyes, but at the time of final examination vision was improved in only 47 eyes, primarily because of the occurrence or progression of nuclear sclerosis, which occurred in 38 of 60 phakic eyes.
Journal ArticleDOI

Progression of Nuclear Sclerosis and Long-term Visual Results of Vitrectomy With Transforming Growth Factor Beta-2 for Macular Holes

TL;DR: The visual acuity often decreases 12 or more months after vitrectomy because of cataract progression, but the visual results of vit rectomy and transforming growth factor beta-2 for macular holes are excellent when the cataracts are removed.
Journal ArticleDOI

Intraocular tamponade duration and success of macular hole surgery.

TL;DR: A long duration intraocular gas tamponade with 16% C3F8 gives a substantially higher success rate for macular hole surgery than a short (5% C1F8), intermediate duration (10% C2F8) or intermediate duration(s) intraocularGas tamponades used in a prospective consecutive clinical trial at two institutions.
Journal ArticleDOI

Advantages and limitations of small gauge vitrectomy.

TL;DR: There are some increased complications related to small gauge vitrectomy, including dislocation of cannulas intraoperatively, early postoperative hypotony, choroidal detachment, and possibly an increased risk of infectious endophthalmitis.
Journal ArticleDOI

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

Alex S. Willoughby, +861 more
- 01 Sep 2015 - 
TL;DR: In eyes with neovascular age-related macular degeneration (AMD), SHRM is common and often persists after anti-vascular endothelial growth factor treatment, and greater SHRM dimensions were associated with worse VA.